Citigroup
NXL icon

Citigroup’s Nexalin Technology NXL Stock Holding History

Citigroup’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481 Buy
+49
New +$604 ﹤0.01% 5460
2025
Q4 		– Sell
-3
Closed -$81 – 6337
2025
Q3 		$81 Buy
+3
New +$85 ﹤0.01% 5819
2024
Q3 		– Hold
0
– -$2 – 5770
2024
Q2 		– Hold
0
– – – 5542

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citigroup's NXL Position: Q2 2026 in Review

Citigroup opened a new position in Nexalin Technology (NXL) in Q2 2026: 49 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #5460 among its holdings. This is a return to the name: Citigroup previously reported a position in NXL as recently as Q3 2025.

Citigroup first reported a position in NXL in Q3 2025 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Citigroup held 49 shares of Nexalin Technology worth $481 as of Q2 2026.
  • Nexalin Technology was a new Citigroup position in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5460 holding.
  • Citigroup first reported a position in Nexalin Technology in Q3 2025 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.